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Abstract
Aims/hypothesis The aim of the study was to examine trends in the incidence and case fatality of acute myocardial infarction
(AMI) and in hospital admissions for angina and coronary revascularisation procedures in people with type 2 diabetes and in
people without diabetes in Scotland between 2006 and 2015.
Methods In this retrospective cohort study, AMI, angina and revascularisation event data were obtained for adults from hospital
admissions and death records linked to a population-based diabetes register. Incidence by diabetes status was estimated using
negative binomial models with adjustment or stratification by age, sex, deprivation and calendar year. Logistic regression was
used to estimate AMI case fatality by diabetes status.
Results There were 129,926 incident AMI events, 41,263 angina admissions and 69,875 coronary revascularisation procedures
carried out during 34.9 million person-years of follow-up. The adjusted incidence of AMI, angina and revascularisation proce-
dures declined by 2.0% (95%CI 1.73%, 2.26%), 9.62% (95%CI 9.22%, 10.01%) and 0.35% (95%CI −0.09%, 0.79%) per year,
respectively. The rate of decline did not differ materially by diabetes status. RRs of AMI for type 2 diabetes were 1.86 (95% CI
1.74, 1.98) for men and 2.32 (95% CI 2.15, 2.51) for women. Of the 77,211 people admitted to hospital with a first AMI, 7842
(10.2%) died within 30 days of admission. Case fatality was higher in people with type 2 diabetes than in people without diabetes
and declined in both groups by 7.93% (95% CI 7.03%, 8.82%) per year.
Conclusions/interpretation The incidence of AMI, angina, revascularisation and AMI case fatality has declined over time, but
the increased risk associated with type 2 diabetes has remained approximately constant.
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Introduction
Type 2 diabetes is known to be associatedwith an elevated risk of
cardiovascular disease (CVD) morbidity and mortality. In partic-
ular, people with type 2 diabetes have previously been shown to
have up to a fivefold higher incidence of acute myocardial in-
farction (AMI) compared with people without diabetes [1–4].
Downward trends in the incidence of AMI have occurred in
recent decades among people without diabetes in high income
countries, partly due to improvements in the prevention and
treatment of CVD [5]. Changes in the investigation of AMI, in
the form of more sensitive tests and lower diagnostic thresholds,
and increasing use of revascularisation procedures, might also
have had different effects on patterns of hospital admission for
CVD including AMI, angina and revascularisation in people
with and without diabetes. Moreover, there have been consider-
able efforts to reduce the risk of CVD specifically in people with
type 2 diabetes, through more intensive risk factor control and
newer diabetes treatments purported to confer specific cardio-
vascular benefits [6, 7]. It is not known whether these ap-
proaches have had an effect on the higher risk of CHD conferred
by type 2 diabetes. Consequently, there is a need for information
on trends in the incidence of AMI, angina and procedures for
CHD in people with diabetes. Scotland’s large representative
whole population-linked datasets provide an opportunity to ad-
dress this question. We examined trends in the incidence and
case fatality of AMI and in hospital admissions for angina and
revascularisation procedures in the Scottish adult population
with type 2 diabetes compared with the non-diabetic population
over the period 2006–2015.
Methods
Data sources Data for the analyses were obtained from three
sources. Mid-year population estimates by age, sex, calendar
year and deciles of the 2012 Scottish Index of Multiple
Deprivation (SIMD) were obtained from National Records
of Scotland.
Data on type 2 diabetes diagnoses were obtained from the
Scottish Care Information—Diabetes (SCI-Diabetes) dataset
[8]. This dynamic clinical register was established in 2000; from
2006 onwards, coverage of the register was estimated to exceed
95% and is now above 99.5%. Diabetes type was defined using
an algorithm which utilises age at diagnosis, prescriptions data
and clinically assigned type of diabetes [9]. Deprivation was
measured using the SIMD, an area-based measure of deprivation
which uses information from seven domains including unem-
ployment rates, crime and income to assign a deprivation score
to 6976 small data zones in Scotland [10]. The data zones are
ranked and grouped into deciles.
Event data were obtained from the Scottish Morbidity
Records (SMR01) database, which captures all hospital admis-
sions in Scotland, and from national death records. The primary
endpoint was AMI, defined as a first hospital admission with a
stated clinical diagnosis of AMI or CHD death, identified using
ICD-10 codes I21-22 or I20-I25, respectively (http://apps.who.
int/classifications/icd10/browse/2016/en). Secondary endpoints
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included incidence of hospital admissions or death due to angina
(I20) and incidence of revascularisation procedures, identified
using the fourth revision of the Office of Population Censuses
and Surveys Classification of Interventions and Procedures:
K40-K50, K75. Where there were multiple hospital episodes
for a single incident event, the chronologically earliest episode
was used. People with a history of the endpoints prior to entry
to the cohort (based on date of diagnosis of diabetes and age and
calendar time points, as appropriate) or who had incomplete dep-
rivation data were excluded from the analyses. Case fatality was
defined as deathwithin 30 days following hospital admissionwith
AMI. SCI-Diabetes, the SMR01 and death registrations were
linked using the Community Health Index, a unique patient iden-
tifier, and probabilistic linkage methods [11]. Data linkage is well
established in Scotland and, thanks to the widespread use of the
Community Health Index in medical records, over 98% of re-
cords are able to be linked [12]. Generation of the anonymised
linked dataset was approved by the Scotland Multi-Centre
Research Ethics Committee (reference 11-AL-0225), Caldicott
Guardians and the National Health Service (NHS) National
Services Scotland Privacy Application Committee (reference 33/
11); individual informed consent is not required for the linkage.
Statistical analyses Analyses were restricted to people aged be-
tween 30 and 89 years at any time during the study period,
because of the small numbers of events outside this age range.
The study period was between 1 January 2006 and 31 December
2015. Follow-up was from study start date for people with prev-
alent diabetes at this point or from date of diagnosis of diabetes, if
between 2006 and 2015, until date of death, date of incident
event or study end date, whichever came first. To calculate inci-
dent events and person-years in the non-diabetic comparison
group, the number of incident events and person-years at risk
for the population of people with any type of diabetes was
subtracted from the number of events and the mid-year popula-
tion estimates for thewhole population, respectively. All analyses
were conducted separately for men and women.
The AER package in R (R Foundation for Statistical
Computing, Vienna, Austria) was used to apply Cameron and
Trivedi’s test for over-dispersion [13, 14]. As there was some
evidence of over-dispersion in the datasets (electronic supple-
mentary material [ESM] Table 1), negative binomial regression
models, stratified by sex and diabetes status, adjusted for age,
calendar year and deciles of SIMD, were used to calculate
standardised incidence rates and RRs for AMI, angina and
revascularisation. An interaction term between diabetes status
and deprivation was included in the models, since deprivation
has previously been shown to modify the relationship between
type 2 diabetes and CVD [15]. An interaction term between
diabetes status and calendar year was also included to examine
whether the association between type 2 diabetes and risk of AMI
had changed over time. Other interaction terms between year,
diabetes type, sex and deprivation were included where RRs
associated with the interaction were <0.95 or >1.05 (ESM
Table 2). Logistic regression models adjusted for age, sex, calen-
dar year and deprivation were used to estimate the odds of case
fatality following hospital admission with AMI associated with
type 2 diabetes. All analyses were conducted in R, version 3.2.2.
Results
Overall, 129,926 AMI events, 41,263 angina admissions and
69,875 coronary revascularisations were recorded during 34.9
million person-years of follow-up between 2006 and 2015 in
Scotland. Of the AMI events, 24,390 (18.8%) occurred among
people with type 2 diabetes. The crude incidence of AMI was
3.21 and 11.75 per 1000 person-years among people without
diabetes and with type 2 diabetes, respectively. The proportion
of AMI events that were fatal prior to hospital admission was
higher in men with type 2 diabetes than in men without dia-
betes, but proportions were similar by diabetes status in wom-
en (Table 1).
Incidence Figure 1 illustrates estimated AMI incidence by age
and sex for people with type 2 diabetes and without diabetes
from negative binomial models adjusted for calendar year and
deprivation among people within deprivation quintile 5 in
2010. AMI incidence increased with age, was higher in men
than in women, and was higher in people with type 2 diabetes
than in people without diabetes. Overall, type 2 diabetes con-
ferred a higher RR of AMI in women (2.32; 95% CI 2.15,
2.51) than in men (1.86; 95% CI 1.74, 1.98). Increasing dep-
rivation was associated with AMI risk, which was 1.52 times
(95% CI 1.50, 1.54) higher in the most deprived compared
with the least deprived decile for men and 1.56 (95% CI 1.54,
1.58) times higher for women.
Similar patterns of higher incidence among people with
type 2 diabetes compared with people without diabetes were
observed for angina and coronary revascularisation (ESMFig.
1, ESM Fig. 2).
Time trends The absolute numbers of events by calendar year,
sex and diabetes status are presented in Table 2 and ESM
Table 3. The proportion of people who had an incident AMI
event and who had been diagnosed with type 2 diabetes in-
creased from 19.2% in 2006 to 28.2% in 2015. The total
number of AMI events increased between 2009 and 2010
alongside reductions in the number of angina admissions.
The number of coronary revascularisations each year over
the study period remained approximately constant in people
without diabetes but increased in people with type 2 diabetes.
Overall, after adjusting for age and deprivation, the inci-
dence of AMI declined, on average, by 2.0% (95% CI 1.73%,
2.26%) per year (see example presented in Fig. 2) and there
was no evidence that time trends differed appreciably by
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diabetes status (RR for year × diabetes interaction 1.01; 95%
CI 1.00, 1.02). The incidence of angina and coronary
revascularisation declined by 9.62% (95% CI 9.22%,
10.01%) and 0.35% (95% CI −0.09%, 0.79%), respectively
(ESM Fig. 3, ESM Fig. 4). Declines in adjusted incidence of
angina and revascularisation were also similar in people with
type 2 diabetes and without diabetes (RRs for year × diabetes
in te rac t ions : angina 1 .01 [95% CI 1.00 , 1 .02] ;
revascularisation 1.00 [95% CI 0.99, 1.01]).
Case fatality Of the 77,211 people hospitalised due to AMI,
7842 (10.2%) died within 30 days of hospital admission. Case
fatality was higher in people with type 2 diabetes than in
people without diabetes (13% vs 9.5%) and higher in women
compared with men (13% vs 8.5%), and it increased with
increasing age (ESM Fig. 5). In adjusted logistic regression
models, type 2 diabetes conferred a similar excess odds of
case fatality in men (OR 1.22; 95% CI 1.13, 1.32) and women
(OR 1.19; 95% CI 1.09, 1.30). Case fatality following AMI
declined, on average, by 7.93% (95% CI 7.03%, 8.82%) per
year during the study period, and the rate of decline was sim-
ilar in people with type 2 diabetes and people without diabetes
(RR for interaction 1.00; 95% CI 0.98, 1.02) (Fig. 3). The
greatest declines in case fatality occurred in the earlier years
of the study period.
Discussion
In this population-based study, we report declining age- and
deprivation-adjusted incidence of AMI, angina and coronary
revascularisations in Scotland between 2006 and 2015, re-
gardless of diabetes status. Despite improvements in absolute
risk, the risk of AMI remained 1.9–2.3 times higher in people
with type 2 diabetes compared with people without diabetes.
This suggests that changes in diagnostic practice, measures to
address cardiovascular risk factors and introduction of new
treatments for diabetes in recent years have not had a discern-
ible differential effect in people with type 2 diabetes compared
with people without diabetes.
Similarly, 30 day case fatality following hospital admission
with AMI improved over time both in people with type 2
diabetes and in people without diabetes but remained consis-
tently higher in people with type 2 diabetes.
Relation to other studies Our findings of stable RRs of first
AMI in both men and women with type 2 diabetes are in
agreement with some [2, 16, 17] but not all [3, 18–20] earlier
findings. In the UK, type 1 and type 2 diabetes conferred a
Fig. 1 Incidence of AMI by diabetes status, sex and age in years. The
graphs illustrate modelled rates for (a) men and (b) women in deprivation
decile 5 in the calendar year 2010 using negative binomial models. The
shading shows 95% CIs. Points represent event rates stratified by age in
5-year bands, sex and diabetes diagnosis; the size of the points reflects the
size of the denominator
Table 1 Number of events by type of CHD, timing relative to admis-
sion for AMI, diabetes status and sex











AMI event (AMI or CHD death)
Men
No diabetes 25,134 (38.3) 40,477 (61.7) 3171 (7.8)
Type 2 diabetes 6645 (44.0) 8448 (56.0) 987 (11.7)
Women
No diabetes 16,853 (42.2) 23,072 (57.8) 2897 (12.6)
Type 2 diabetes 4083 (43.9) 5214 (56.1) 787 (15.1)
Angina
Men
No diabetes 18,584 –
Type 2 diabetes 4725 –
Women
No diabetes 14,809 –
Type 2 diabetes 3145 –
Coronary revascularisation
Men
No diabetes – 42,497 –
Type 2 diabetes – 8382 –
Women
No diabetes – 15,770 –
Type 2 diabetes – 3226 –
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four- to fivefold increased risk of AMI and this excess risk did
not change significantly between 2004 and 2009; however,
these estimates include recurrent events, so they are not direct-
ly comparable [2, 21]. By contrast, findings from the US
National Health Interview Survey show that the RRs of AMI
in people with diabetes compared with the non-diabetic pop-
ulation declined from 2.8 in 2000 to 1.8 in 2010 [3]. Similar
reductions in incidence rate ratios for CHD in people with
diabetes compared with the non-diabetic population were ob-
served between 1998 and 2010 in Western Australia [19]. It is
possible that these conflicting findings reflect differences in
health services between populations.
Improvements in CHD incidence for people with and with-
out diabetes in high income countries are likely to reflect
population-wide reductions in smoking prevalence [22], re-
duced dietary salt intake [23, 24] and improved treatment of
hypertension and dyslipidaemia. For example, smoking prev-
alence declined from 28% to 21% between 2003 and 2015 in
the Scottish general population and from 21.4% to 18.1%
between 2005 and 2015 in the diabetes population [25, 26].
The Quality and Outcomes Framework incentivised improved
management of CVD risk in primary care among people with
chronic diseases such as type 2 diabetes and was introduced
across the UK in 2004. This might have been expected to
result in more rapid declines in CVD risk in people with dia-
betes compared with the non-diabetic population, although
better management of other risk factors such as hypertension
was supported by the scheme regardless of diabetes status.
Unfortunately, population-wide data for trends in AMI among
people with type 2 diabetes prior to 2004 in Scotland were not
available to enable us to describe earlier RR estimates.
Nonetheless, our finding of unchanging RRs for CHD by
diabetes status is perhaps surprising given the additional sup-
port for risk factor management and that the characteristics of
people with newly diagnosed type 2 diabetes are likely to have
changed in recent years [27]. Diagnosis of diabetes earlier in
the disease might have been expected to result in faster de-
clines in AMI incidence among people with type 2 diabetes
than in people without diabetes [28]. However, we did not
observe this pattern, suggesting that any such effects might
Table 2 Number of CHD events by calendar year, sex and diabetes status
CHD type 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Overall
AMI or CHD death
Men
No diabetes 6487 6479 6532 6563 6936 6797 6787 6514 6290 6226 65,611
Type 2 diabetes 1218 1317 1343 1488 1597 1545 1676 1614 1568 1727 15,093
Events in men with type 2 diabetes, % 15.8 16.9 17.1 18.5 18.7 18.5 19.8 19.9 20.0 21.7 18.7
Women
No diabetes 4398 4092 4126 4123 4184 4030 4101 3774 3616 3481 39,925
Type 2 diabetes 875 778 847 924 948 999 955 1026 934 1011 9297
Events in women with type 2 diabetes, % 16.6 16.0 17.0 18.3 18.5 19.9 18.9 21.4 20.5 22.5 18.9
Angina
Men
No diabetes 2440 2619 2534 2123 1854 1465 1435 1429 1378 1307 18,584
Type 2 diabetes 531 572 560 468 505 384 378 445 426 456 4725
Events in men with type 2 diabetes, % 17.9 17.9 18.1 18.1 21.4 20.8 20.8 23.7 23.6 25.9 20.3
Women
No diabetes 2002 2064 2081 1664 1444 1153 1158 1157 1099 987 14,809
Type 2 diabetes 361 385 397 369 319 283 236 282 250 263 3145
Events in women with type 2 diabetes 15.3 15.7 16.0 18.2 18.1 19.7 16.9 19.6 18.5 21.0 17.5
Coronary revascularisation
Men
No diabetes 4065 4197 4007 4070 4255 4286 4395 4497 4424 4301 42,497
Type 2 diabetes 685 763 723 783 818 828 903 912 969 998 8382
Events in men with type 2 diabetes, % 14.4 15.4 15.3 16.1 16.1 16.2 17.0 16.9 18.0 18.8 16.5
Women
No diabetes 1572 1635 1544 1479 1546 1574 1617 1628 1628 1547 15,770
Type 2 diabetes 295 268 258 337 316 338 287 361 376 390 3226
Events in women with type 2 diabetes, % 15.8 14.1 14.3 18.6 17.0 17.7 15.1 18.1 18.8 20.1 17.0
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have occurred prior to 2006, or that a longer period of follow-up
is required before the effect of earlier diagnosis of diabetes can
be observed at a population level. Furthermore, obesity preva-
lence increased by a greater extent in people with type 2 diabe-
tes than in the general population in Scotland between 2005 and
2013, which, along with patterns of other risk factors such as
physical inactivity that may have changed over the study period
either differentially or non-differentially by diabetes status,
might also have influenced our findings [25, 26].
Whilewe report average annual declines of 2.0% in incidence
of AMI, it is clear that AMI incidence increased slightly (and
angina incidence fell) following the introduction of lowered tro-
ponin thresholds to diagnose AMI in 2008. The increase after
2008 was less marked in women, which may reflect the use of a
single revised diagnostic threshold for men and women at this
time. Subsequent validation of the newer high sensitivity tropo-
nin assay suggested that sex-specific thresholds were required to
avoid underdiagnosis of AMI in women [29]. The introduction
of more sensitive diagnostic tools for AMI is likely to have led to
the diagnosis of less severeAMI, particularly among peoplewho
might have previously received a diagnosis of angina, and could
partly account for the steep declines in 30 day case fatality fol-
lowing hospital admission with incident AMI and in the declines
in angina incidence rates inmore recent years. Unfortunately, we
did not have access to data on the introduction of new assays and
thresholds across Scotland.
Higher RRs of incident AMI for people with diabetes com-
pared with people without diabetes and for women compared
with men have been reported previously [18, 30]. In one meta-
analysis, the RR of incident CHD associated with diabetes
was 44% greater in women than in men [30]. Mechanisms
for this sex disparity include differences in prevalence and
management of cardiovascular risk factors by sex and diabetes
status [31, 32]. However, in a recent meta-analysis including
data for 980,793 people, the RRs of diabetes for vascular
mortality remained much higher in women than in men even
after adjustment for CVD risk factors [33].
Strengths and weaknesses Our estimates of trends in the inci-
dence of first AMI, angina and coronary revascularisation are
based on a complete national population and are therefore un-
likely to be have been affected by selection bias. We were also
able to identify people with a diagnosis of type 2 diabetes from
the national diabetes register, rather than depending on hospital
admission records in which diabetes is under-reported [33].
Unfortunately, the accuracy of recording of incident AMI
events in routinely collected data may not be perfect.
However, the data sources are audited annually and the re-
corded diagnosis was found to be correct for >95% of AMI
events [34]; it seems unlikely that a discrepancy in accuracy of
recording of AMI by diabetes status contributed to our
Fig. 3 Case fatality within 30 days of hospital admission following AMI
in (a) men and (b) women aged 55, 65 and 75 years, by calendar year and
diabetes status. Estimates derived from model adjusted for age, sex, cal-
endar year, deprivation status and interaction terms between sex and year,
sex and diabetes status, deprivation and diabetes status, diabetes status
and year. The line colour depicts the age and the line type depicts the
diabetes status. The shading shows 95% CIs
Fig. 2 Trends in incidence of AMI by diabetes status and calendar year
illustrated for (a) men and (b) women in deprivation decile 5 and aged 55,
65 and 75 years. Estimates derived from the model are adjusted for age,
sex, deprivation and interaction terms between sex and year, sex and
diabetes status, diabetes status and year. The line colour depicts the age
and the line type depicts the diabetes status. The shading shows 95% CIs
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findings. Similarly, we are not able to exclude the potential for
misclassification of vital status if the proportions of people
who die outside Scotland differ by diabetes status. We were
unable to adjust estimates for important confounders includ-
ing CVD risk factors, since we did not have access to these
data for the general population. We were therefore unable to
determine how risk factor patterns had changed over time or to
what extent differences in risk factors contributed to the dis-
parity in AMI incidence between people with type 2 diabetes
and people without diabetes. Given that diabetes is associated
with worse CVD risk factor profiles [35], it is fair to assume
that the excess risk of CHD observed in this study was in part
due to differences in the distribution of CVD risk factors be-
tween the groups. Our study was also limited by the inability
to separate ST-elevation (STEMI) from non-ST-elevation
(NSTEMI) AMI events.
Conclusions
The incidence of AMI, angina and revascularisation pro-
cedures declined at similar rates in people with and
without type 2 diabetes in Scotland between 2006 and
2015. Compared with people without diabetes, the risk
of incident CHD remained considerably higher among
people with type 2 diabetes, who also had higher
30 day case fatality following hospital admission with
AMI. These findings have important implications for
primary and secondary prevention of CHD in the future,
given the growing prevalence of type 2 diabetes and an
ageing population.
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